Found 10 hits Enz. Inhib. hit(s) with all data for entry = 50000503 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Induced myeloid leukemia cell differentiation protein Mcl-1
(Homo sapiens (Human)) | BDBM50244142
(CHEMBL4086356 | US10533010, Example I-240 | US1120...)Show SMILES Cc1nn(C)c(C)c1-c1c(Cl)ccc2c(CCCOc3cc(C)c(Cl)c(C)c3)c3C(=O)N(CCCn3c12)c1cc(cc2n(C)ccc12)C(O)=O |(28.45,-6,;26.98,-5.52,;26.5,-4.06,;24.96,-4.06,;24.05,-2.82,;24.49,-5.53,;23.03,-6.01,;25.74,-6.43,;25.75,-7.98,;24.42,-8.75,;23.09,-7.98,;24.42,-10.29,;25.75,-11.06,;27.08,-10.29,;28.56,-10.77,;29.04,-12.24,;30.54,-12.56,;31.02,-14.02,;32.52,-14.34,;33,-15.81,;34.5,-16.12,;34.98,-17.58,;36.49,-17.89,;33.95,-18.73,;34.43,-20.2,;32.44,-18.41,;31.41,-19.55,;31.97,-16.95,;29.47,-9.51,;31.03,-9.58,;31.64,-10.99,;32.05,-8.4,;31.76,-6.87,;30.39,-6.14,;28.97,-6.76,;28.56,-8.26,;27.08,-8.74,;33.53,-8.8,;34.61,-7.71,;36.09,-8.11,;36.5,-9.6,;35.4,-10.69,;35.48,-12.22,;36.77,-13.06,;34.05,-12.77,;33.08,-11.57,;33.92,-10.29,;37.18,-7.02,;36.78,-5.53,;38.67,-7.41,)| Show InChI InChI=1S/C39H39Cl2N5O4/c1-21-17-26(18-22(2)35(21)41)50-16-7-9-27-28-10-11-30(40)34(33-23(3)42-44(6)24(33)4)36(28)46-14-8-13-45(38(47)37(27)46)32-20-25(39(48)49)19-31-29(32)12-15-43(31)5/h10-12,15,17-20H,7-9,13-14,16H2,1-6H3,(H,48,49) | PDB
MMDB
NCI pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
PDB
UniChem
Similars
| PDB
Article
PubMed
| 0.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vanderbilt University
Curated by ChEMBL
| Assay Description
Inhibition of FITC-Bak-BH3 binding to recombinant MBP-fused MCL1 (172 to 318 residues) (unknown origin) in presence of 1% FBS by TR-FRET assay |
Bioorg Med Chem 25: 3087-3092 (2017)
Article DOI: 10.1016/j.bmc.2017.03.060
BindingDB Entry DOI: 10.7270/Q2154KGG |
More data for this
Ligand-Target Pair | 
3D Structure (crystal) |
Induced myeloid leukemia cell differentiation protein Mcl-1
(Homo sapiens (Human)) | BDBM50244142
(CHEMBL4086356 | US10533010, Example I-240 | US1120...)Show SMILES Cc1nn(C)c(C)c1-c1c(Cl)ccc2c(CCCOc3cc(C)c(Cl)c(C)c3)c3C(=O)N(CCCn3c12)c1cc(cc2n(C)ccc12)C(O)=O |(28.45,-6,;26.98,-5.52,;26.5,-4.06,;24.96,-4.06,;24.05,-2.82,;24.49,-5.53,;23.03,-6.01,;25.74,-6.43,;25.75,-7.98,;24.42,-8.75,;23.09,-7.98,;24.42,-10.29,;25.75,-11.06,;27.08,-10.29,;28.56,-10.77,;29.04,-12.24,;30.54,-12.56,;31.02,-14.02,;32.52,-14.34,;33,-15.81,;34.5,-16.12,;34.98,-17.58,;36.49,-17.89,;33.95,-18.73,;34.43,-20.2,;32.44,-18.41,;31.41,-19.55,;31.97,-16.95,;29.47,-9.51,;31.03,-9.58,;31.64,-10.99,;32.05,-8.4,;31.76,-6.87,;30.39,-6.14,;28.97,-6.76,;28.56,-8.26,;27.08,-8.74,;33.53,-8.8,;34.61,-7.71,;36.09,-8.11,;36.5,-9.6,;35.4,-10.69,;35.48,-12.22,;36.77,-13.06,;34.05,-12.77,;33.08,-11.57,;33.92,-10.29,;37.18,-7.02,;36.78,-5.53,;38.67,-7.41,)| Show InChI InChI=1S/C39H39Cl2N5O4/c1-21-17-26(18-22(2)35(21)41)50-16-7-9-27-28-10-11-30(40)34(33-23(3)42-44(6)24(33)4)36(28)46-14-8-13-45(38(47)37(27)46)32-20-25(39(48)49)19-31-29(32)12-15-43(31)5/h10-12,15,17-20H,7-9,13-14,16H2,1-6H3,(H,48,49) | PDB
MMDB
NCI pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
PDB
UniChem
Similars
| PDB
Article
PubMed
| 0.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vanderbilt University
Curated by ChEMBL
| Assay Description
Inhibition of FITC-Bak-BH3 binding to recombinant MBP-fused MCL1 (172 to 318 residues) (unknown origin) by TR-FRET assay |
Bioorg Med Chem 25: 3087-3092 (2017)
Article DOI: 10.1016/j.bmc.2017.03.060
BindingDB Entry DOI: 10.7270/Q2154KGG |
More data for this
Ligand-Target Pair |
3D Structure (crystal) |
Induced myeloid leukemia cell differentiation protein Mcl-1
(Homo sapiens (Human)) | BDBM50244142
(CHEMBL4086356 | US10533010, Example I-240 | US1120...)Show SMILES Cc1nn(C)c(C)c1-c1c(Cl)ccc2c(CCCOc3cc(C)c(Cl)c(C)c3)c3C(=O)N(CCCn3c12)c1cc(cc2n(C)ccc12)C(O)=O |(28.45,-6,;26.98,-5.52,;26.5,-4.06,;24.96,-4.06,;24.05,-2.82,;24.49,-5.53,;23.03,-6.01,;25.74,-6.43,;25.75,-7.98,;24.42,-8.75,;23.09,-7.98,;24.42,-10.29,;25.75,-11.06,;27.08,-10.29,;28.56,-10.77,;29.04,-12.24,;30.54,-12.56,;31.02,-14.02,;32.52,-14.34,;33,-15.81,;34.5,-16.12,;34.98,-17.58,;36.49,-17.89,;33.95,-18.73,;34.43,-20.2,;32.44,-18.41,;31.41,-19.55,;31.97,-16.95,;29.47,-9.51,;31.03,-9.58,;31.64,-10.99,;32.05,-8.4,;31.76,-6.87,;30.39,-6.14,;28.97,-6.76,;28.56,-8.26,;27.08,-8.74,;33.53,-8.8,;34.61,-7.71,;36.09,-8.11,;36.5,-9.6,;35.4,-10.69,;35.48,-12.22,;36.77,-13.06,;34.05,-12.77,;33.08,-11.57,;33.92,-10.29,;37.18,-7.02,;36.78,-5.53,;38.67,-7.41,)| Show InChI InChI=1S/C39H39Cl2N5O4/c1-21-17-26(18-22(2)35(21)41)50-16-7-9-27-28-10-11-30(40)34(33-23(3)42-44(6)24(33)4)36(28)46-14-8-13-45(38(47)37(27)46)32-20-25(39(48)49)19-31-29(32)12-15-43(31)5/h10-12,15,17-20H,7-9,13-14,16H2,1-6H3,(H,48,49) | PDB
MMDB
NCI pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
PDB
UniChem
Similars
| PDB
Article
PubMed
| 1.40 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vanderbilt University
Curated by ChEMBL
| Assay Description
Inhibition of FITC-Bak-BH3 binding to recombinant MBP-fused MCL1 (172 to 318 residues) (unknown origin) in presence of 1% FBS by TR-FRET assay |
Bioorg Med Chem 25: 3087-3092 (2017)
Article DOI: 10.1016/j.bmc.2017.03.060
BindingDB Entry DOI: 10.7270/Q2154KGG |
More data for this
Ligand-Target Pair |
3D Structure (crystal) |
Induced myeloid leukemia cell differentiation protein Mcl-1
(Homo sapiens (Human)) | BDBM50244142
(CHEMBL4086356 | US10533010, Example I-240 | US1120...)Show SMILES Cc1nn(C)c(C)c1-c1c(Cl)ccc2c(CCCOc3cc(C)c(Cl)c(C)c3)c3C(=O)N(CCCn3c12)c1cc(cc2n(C)ccc12)C(O)=O |(28.45,-6,;26.98,-5.52,;26.5,-4.06,;24.96,-4.06,;24.05,-2.82,;24.49,-5.53,;23.03,-6.01,;25.74,-6.43,;25.75,-7.98,;24.42,-8.75,;23.09,-7.98,;24.42,-10.29,;25.75,-11.06,;27.08,-10.29,;28.56,-10.77,;29.04,-12.24,;30.54,-12.56,;31.02,-14.02,;32.52,-14.34,;33,-15.81,;34.5,-16.12,;34.98,-17.58,;36.49,-17.89,;33.95,-18.73,;34.43,-20.2,;32.44,-18.41,;31.41,-19.55,;31.97,-16.95,;29.47,-9.51,;31.03,-9.58,;31.64,-10.99,;32.05,-8.4,;31.76,-6.87,;30.39,-6.14,;28.97,-6.76,;28.56,-8.26,;27.08,-8.74,;33.53,-8.8,;34.61,-7.71,;36.09,-8.11,;36.5,-9.6,;35.4,-10.69,;35.48,-12.22,;36.77,-13.06,;34.05,-12.77,;33.08,-11.57,;33.92,-10.29,;37.18,-7.02,;36.78,-5.53,;38.67,-7.41,)| Show InChI InChI=1S/C39H39Cl2N5O4/c1-21-17-26(18-22(2)35(21)41)50-16-7-9-27-28-10-11-30(40)34(33-23(3)42-44(6)24(33)4)36(28)46-14-8-13-45(38(47)37(27)46)32-20-25(39(48)49)19-31-29(32)12-15-43(31)5/h10-12,15,17-20H,7-9,13-14,16H2,1-6H3,(H,48,49) | PDB
MMDB
NCI pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
PDB
UniChem
Similars
| PDB
Article
PubMed
| 1.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vanderbilt University
Curated by ChEMBL
| Assay Description
Inhibition of FITC-Bak-BH3 binding to recombinant MBP-fused MCL1 (172 to 318 residues) (unknown origin) in presence of BSA by TR-FRET assay |
Bioorg Med Chem 25: 3087-3092 (2017)
Article DOI: 10.1016/j.bmc.2017.03.060
BindingDB Entry DOI: 10.7270/Q2154KGG |
More data for this
Ligand-Target Pair |
3D Structure (crystal) |
Induced myeloid leukemia cell differentiation protein Mcl-1
(Homo sapiens (Human)) | BDBM50251649
(CHEMBL4064457)Show SMILES CN(C)CCOCc1nn(C)c(C)c1-c1cccc2c(CCCOc3cc(C)c(Cl)c(C)c3)c([nH]c12)C(O)=O |(38.45,-25.57,;37.31,-26.61,;37.63,-28.11,;35.84,-26.13,;34.7,-27.17,;33.24,-26.7,;32.09,-27.73,;30.63,-27.26,;30.15,-25.8,;28.61,-25.8,;27.7,-24.56,;28.14,-27.27,;26.67,-27.75,;29.39,-28.17,;29.4,-29.7,;28.07,-30.47,;28.06,-32.02,;29.4,-32.79,;30.74,-32.01,;32.21,-32.48,;32.69,-33.94,;31.67,-35.09,;32.16,-36.55,;31.13,-37.7,;31.62,-39.16,;30.59,-40.31,;31.07,-41.77,;30.05,-42.92,;32.58,-42.08,;33.07,-43.54,;33.61,-40.92,;35.12,-41.23,;33.12,-39.47,;33.11,-31.22,;32.2,-29.98,;30.73,-30.47,;34.65,-31.21,;35.41,-29.88,;35.43,-32.54,)| Show InChI InChI=1S/C30H37ClN4O4/c1-18-15-21(16-19(2)27(18)31)39-13-8-11-23-22-9-7-10-24(28(22)32-29(23)30(36)37)26-20(3)35(6)33-25(26)17-38-14-12-34(4)5/h7,9-10,15-16,32H,8,11-14,17H2,1-6H3,(H,36,37) | PDB
MMDB
NCI pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vanderbilt University
Curated by ChEMBL
| Assay Description
Inhibition of FITC-Bak-BH3 binding to recombinant MBP-fused MCL1 (172 to 318 residues) (unknown origin) by TR-FRET assay |
Bioorg Med Chem 25: 3087-3092 (2017)
Article DOI: 10.1016/j.bmc.2017.03.060
BindingDB Entry DOI: 10.7270/Q2154KGG |
More data for this
Ligand-Target Pair | |
Induced myeloid leukemia cell differentiation protein Mcl-1
(Homo sapiens (Human)) | BDBM50251650
(CHEMBL4099902)Show SMILES Cc1c(c(CN2CCCCC2)nn1C)-c1cccc2c(CCCOc3cc(C)c(Cl)c(C)c3)c([nH]c12)C(O)=O |(7.32,-26.12,;8.79,-25.64,;10.03,-26.54,;11.28,-25.63,;12.74,-26.1,;13.88,-25.07,;15.35,-25.55,;16.49,-24.52,;16.17,-23.01,;14.7,-22.54,;13.55,-23.57,;10.8,-24.17,;9.26,-24.17,;8.35,-22.93,;10.04,-28.08,;8.72,-28.85,;8.71,-30.39,;10.05,-31.16,;11.39,-30.38,;12.86,-30.85,;13.34,-32.31,;12.32,-33.46,;12.8,-34.92,;11.78,-36.08,;12.26,-37.54,;11.24,-38.68,;11.72,-40.14,;10.7,-41.29,;13.23,-40.46,;13.72,-41.92,;14.26,-39.3,;15.77,-39.6,;13.77,-37.84,;13.76,-29.6,;12.84,-28.36,;11.38,-28.84,;15.3,-29.59,;16.06,-28.25,;16.08,-30.92,)| Show InChI InChI=1S/C31H37ClN4O3/c1-19-16-22(17-20(2)28(19)32)39-15-9-12-24-23-10-8-11-25(29(23)33-30(24)31(37)38)27-21(3)35(4)34-26(27)18-36-13-6-5-7-14-36/h8,10-11,16-17,33H,5-7,9,12-15,18H2,1-4H3,(H,37,38) | PDB
MMDB
NCI pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 22 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vanderbilt University
Curated by ChEMBL
| Assay Description
Inhibition of FITC-Bak-BH3 binding to recombinant MBP-fused MCL1 (172 to 318 residues) (unknown origin) by TR-FRET assay |
Bioorg Med Chem 25: 3087-3092 (2017)
Article DOI: 10.1016/j.bmc.2017.03.060
BindingDB Entry DOI: 10.7270/Q2154KGG |
More data for this
Ligand-Target Pair | |
Induced myeloid leukemia cell differentiation protein Mcl-1
(Homo sapiens (Human)) | BDBM50251649
(CHEMBL4064457)Show SMILES CN(C)CCOCc1nn(C)c(C)c1-c1cccc2c(CCCOc3cc(C)c(Cl)c(C)c3)c([nH]c12)C(O)=O |(38.45,-25.57,;37.31,-26.61,;37.63,-28.11,;35.84,-26.13,;34.7,-27.17,;33.24,-26.7,;32.09,-27.73,;30.63,-27.26,;30.15,-25.8,;28.61,-25.8,;27.7,-24.56,;28.14,-27.27,;26.67,-27.75,;29.39,-28.17,;29.4,-29.7,;28.07,-30.47,;28.06,-32.02,;29.4,-32.79,;30.74,-32.01,;32.21,-32.48,;32.69,-33.94,;31.67,-35.09,;32.16,-36.55,;31.13,-37.7,;31.62,-39.16,;30.59,-40.31,;31.07,-41.77,;30.05,-42.92,;32.58,-42.08,;33.07,-43.54,;33.61,-40.92,;35.12,-41.23,;33.12,-39.47,;33.11,-31.22,;32.2,-29.98,;30.73,-30.47,;34.65,-31.21,;35.41,-29.88,;35.43,-32.54,)| Show InChI InChI=1S/C30H37ClN4O4/c1-18-15-21(16-19(2)27(18)31)39-13-8-11-23-22-9-7-10-24(28(22)32-29(23)30(36)37)26-20(3)35(6)33-25(26)17-38-14-12-34(4)5/h7,9-10,15-16,32H,8,11-14,17H2,1-6H3,(H,36,37) | PDB
MMDB
NCI pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 32 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vanderbilt University
Curated by ChEMBL
| Assay Description
Inhibition of FITC-Bak-BH3 binding to recombinant MBP-fused MCL1 (172 to 318 residues) (unknown origin) in presence of 1% FBS by TR-FRET assay |
Bioorg Med Chem 25: 3087-3092 (2017)
Article DOI: 10.1016/j.bmc.2017.03.060
BindingDB Entry DOI: 10.7270/Q2154KGG |
More data for this
Ligand-Target Pair | |
Induced myeloid leukemia cell differentiation protein Mcl-1
(Homo sapiens (Human)) | BDBM50251669
(CHEMBL4073037)Show SMILES Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cc(C)c(Cl)c(C)c3)c([nH]c12)C(O)=O |(25.12,-5.86,;26.58,-5.38,;27.05,-3.91,;28.59,-3.91,;29.49,-2.66,;29.07,-5.37,;30.54,-5.84,;27.83,-6.28,;27.84,-7.82,;26.51,-8.59,;26.51,-10.13,;27.84,-10.9,;29.18,-10.12,;30.65,-10.59,;31.14,-12.05,;30.12,-13.2,;30.6,-14.66,;29.58,-15.81,;30.06,-17.28,;29.03,-18.42,;29.52,-19.88,;28.49,-21.03,;31.03,-20.2,;31.51,-21.66,;32.05,-19.04,;33.56,-19.34,;31.56,-17.58,;31.55,-9.34,;30.64,-8.09,;29.18,-8.58,;33.09,-9.33,;33.86,-7.99,;33.87,-10.66,)| Show InChI InChI=1S/C26H28ClN3O3/c1-14-12-18(13-15(2)23(14)27)33-11-7-10-20-19-8-6-9-21(24(19)28-25(20)26(31)32)22-16(3)29-30(5)17(22)4/h6,8-9,12-13,28H,7,10-11H2,1-5H3,(H,31,32) | PDB
MMDB
NCI pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
| Article
PubMed
| 48 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vanderbilt University
Curated by ChEMBL
| Assay Description
Inhibition of FITC-Bak-BH3 binding to recombinant MBP-fused MCL1 (172 to 318 residues) (unknown origin) in presence of 1% FBS by TR-FRET assay |
Bioorg Med Chem 25: 3087-3092 (2017)
Article DOI: 10.1016/j.bmc.2017.03.060
BindingDB Entry DOI: 10.7270/Q2154KGG |
More data for this
Ligand-Target Pair | |
Induced myeloid leukemia cell differentiation protein Mcl-1
(Homo sapiens (Human)) | BDBM50251650
(CHEMBL4099902)Show SMILES Cc1c(c(CN2CCCCC2)nn1C)-c1cccc2c(CCCOc3cc(C)c(Cl)c(C)c3)c([nH]c12)C(O)=O |(7.32,-26.12,;8.79,-25.64,;10.03,-26.54,;11.28,-25.63,;12.74,-26.1,;13.88,-25.07,;15.35,-25.55,;16.49,-24.52,;16.17,-23.01,;14.7,-22.54,;13.55,-23.57,;10.8,-24.17,;9.26,-24.17,;8.35,-22.93,;10.04,-28.08,;8.72,-28.85,;8.71,-30.39,;10.05,-31.16,;11.39,-30.38,;12.86,-30.85,;13.34,-32.31,;12.32,-33.46,;12.8,-34.92,;11.78,-36.08,;12.26,-37.54,;11.24,-38.68,;11.72,-40.14,;10.7,-41.29,;13.23,-40.46,;13.72,-41.92,;14.26,-39.3,;15.77,-39.6,;13.77,-37.84,;13.76,-29.6,;12.84,-28.36,;11.38,-28.84,;15.3,-29.59,;16.06,-28.25,;16.08,-30.92,)| Show InChI InChI=1S/C31H37ClN4O3/c1-19-16-22(17-20(2)28(19)32)39-15-9-12-24-23-10-8-11-25(29(23)33-30(24)31(37)38)27-21(3)35(4)34-26(27)18-36-13-6-5-7-14-36/h8,10-11,16-17,33H,5-7,9,12-15,18H2,1-4H3,(H,37,38) | PDB
MMDB
NCI pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 73 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vanderbilt University
Curated by ChEMBL
| Assay Description
Inhibition of FITC-Bak-BH3 binding to recombinant MBP-fused MCL1 (172 to 318 residues) (unknown origin) in presence of 1% FBS by TR-FRET assay |
Bioorg Med Chem 25: 3087-3092 (2017)
Article DOI: 10.1016/j.bmc.2017.03.060
BindingDB Entry DOI: 10.7270/Q2154KGG |
More data for this
Ligand-Target Pair | |
Induced myeloid leukemia cell differentiation protein Mcl-1
(Homo sapiens (Human)) | BDBM50251669
(CHEMBL4073037)Show SMILES Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cc(C)c(Cl)c(C)c3)c([nH]c12)C(O)=O |(25.12,-5.86,;26.58,-5.38,;27.05,-3.91,;28.59,-3.91,;29.49,-2.66,;29.07,-5.37,;30.54,-5.84,;27.83,-6.28,;27.84,-7.82,;26.51,-8.59,;26.51,-10.13,;27.84,-10.9,;29.18,-10.12,;30.65,-10.59,;31.14,-12.05,;30.12,-13.2,;30.6,-14.66,;29.58,-15.81,;30.06,-17.28,;29.03,-18.42,;29.52,-19.88,;28.49,-21.03,;31.03,-20.2,;31.51,-21.66,;32.05,-19.04,;33.56,-19.34,;31.56,-17.58,;31.55,-9.34,;30.64,-8.09,;29.18,-8.58,;33.09,-9.33,;33.86,-7.99,;33.87,-10.66,)| Show InChI InChI=1S/C26H28ClN3O3/c1-14-12-18(13-15(2)23(14)27)33-11-7-10-20-19-8-6-9-21(24(19)28-25(20)26(31)32)22-16(3)29-30(5)17(22)4/h6,8-9,12-13,28H,7,10-11H2,1-5H3,(H,31,32) | PDB
MMDB
NCI pathway
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
| Article
PubMed
| 262 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vanderbilt University
Curated by ChEMBL
| Assay Description
Inhibition of FITC-Bak-BH3 binding to recombinant MBP-fused MCL1 (172 to 318 residues) (unknown origin) in presence of 1% FBS by TR-FRET assay |
Bioorg Med Chem 25: 3087-3092 (2017)
Article DOI: 10.1016/j.bmc.2017.03.060
BindingDB Entry DOI: 10.7270/Q2154KGG |
More data for this
Ligand-Target Pair | |
Search and Browse
